Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever

PLoS Neglected Tropical Diseases

Volumn 9, Issue 1, 2015, Pages

  Lo Iacono, Giovanni ^a   Cunningham, Andrew A ^b   Fichet Calvet, Elisabeth ^c   Garry, Robert F ^d,e,f   Grant, Donald S ^g   Khan, Sheik Humarr ^g   Leach, Melissa ^h   Moses, Lina M ^d   Schieffelin, John S ^d   Shaffer, Jeffrey G ⁱ   Webb, Colleen T ^j   Wood, James L N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF ZOOLOGY   (United Kingdom)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f Zalgen Labs LLC   (United States)

^g Kenema Government Hospital   (Sierra Leone)

^h UNIVERSITY OF SUSSEX   (United Kingdom)

ⁱ TULANE UNIVERSITY   (United States)

^j Department of Environmental and Radiological Health Sciences   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ANTHROPONOTIC TRANSMISSION; ARTICLE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EPIDEMIC; HOSPITAL INFECTION; HUMAN; LASSA FEVER; LASSA VIRUS; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NONHUMAN; PREDICTION; RODENT; SENSITIVITY ANALYSIS; SIERRA LEONE; VIRUS TRANSMISSION; ZOONOSIS; ANIMAL; BIOLOGICAL MODEL; CROSS INFECTION; TRANSMISSION;

ANIMALS; CROSS INFECTION; HUMANS; LASSA FEVER; MODELS, BIOLOGICAL; SIERRA LEONE; ZOONOSES;

EID: 84922249629     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003398     Document Type: Article

References (56)

1. Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, et al. (2014) Lassa fever in post-conflict Sierra Leone. PLoS Neglected Tropical Diseases 8: e2748.
2. Carey D, Kemp G, White H, Pinneo L, Addy R, et al. (1972) Lassa fever epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 66: 402–408.
3. Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, et al. (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March–April 1972. The American Journal of Tropical Medicine and Hygiene 22: 773–9.
4. Frame JD, Baldwin JM, Gocke DJ, Troup JM, (1970) Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. The American Journal of Tropical Medicine and Hygiene 19: 670–6.
5. Rose J, (1957) An outbreak of encephalomyelitis in Sierra Leone. The Lancet 270: 914–916.
6. Fichet-Calvet E (2014) Lassa Fever. In: The Role of Animals in Emerging Viral Diseases, Academic Press. pp.89–123.
7. Cooper CB, Gransden WR, Webster M, King M, O′Mahony M, et al. (1982) A case of Lassa fever: experience at St Thomas's Hospital. British Medical Journal (Clinical Research Edition) 285: 212.
8. Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A, (1974) Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185: 263–265.
9. Fisher-Hoch S, Craven R, Forthall D, Scott S, Price M, et al. (1985) Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. The Lancet 326: 1227–1229.
10. Helmick C, Scribner C, Webb P, Krebs J, McCormick J, (1986) No evidence for increased risk of Lassa fever infection in hospital staff. The Lancet 328: 1202–1205.
11. Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, et al. (1990) Lassa fever in the United States. Investigation of a case and new guidelines for management. The New England Journal of Medicine 323: 1120–3.
12. Banatvala JE, (1986) Lassa fever. British Medical Journal 293: 1256–1257.
13. Advisory Committee on Dangerous Pathogens (2012). Management and control of viral haemorrhagic fevers (ACDP).
14. Haas WH, Breuer T, Pfaff G, Schmitz H, Köhler P, et al. (2003) Imported Lassa fever in Germany: surveillance and management of contact persons. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America 36: 1254–8.
15. Emond RT, Weir WR, Bowen ET, Lloyd G, Southee T, (1984) Managing Lassa fever. Lancet 2: 926.
16. Monath TP, (1975) Lassa fever: review of epidemiology and epizootiology. Bulletin of the World Health Organization 52: 577–592.
17. Stephenson EH, Larson EW, Dominik JW, (1984) Effect of environmental factors on aerosol-induced Lassa virus infection. Journal of Medical Virology 14: 295–303.
18. Peters CJ, Jahrling PB, Liu CT, Kenyon RH, McKee KT, et al. (1987) Experimental studies of arenaviral hemorrhagic fevers. Current Topics in Microbiology and Immunology 134: 5–68.
19. Sagripanti JL, Rom AM, Holland LE, (2010) Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Archives of Virology 155: 2035–9.
20. Kernéis S, Koivogui L, Magassouba N, Koulemou K, Lewis R, et al. (2009) Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. PLoS Neglected Tropical Diseases 3: e548.
21. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES, (1987) A Prospective study of the epidemiology and ecology of Lassa fever. The Journal of Infectious Diseases 155: 437–444.
22. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, et al. (2009) Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathogens 5: e1000455.
23. Crowcroft NS, Meltzer M, Evans M, Shetty N, Maguire H, et al. (2004) The public health response to a case of Lassa fever in London in 2000. The Journal of Infection 48: 221–8.
24. Macher AM, Wolfe MS, (2006) Historical Lassa fever reports and 30-year clinical update. Emerging Infectious Diseases 12: 835–7.
25. Woodrow CJ, Eziefula AC, Agranoff D, Scott GM, Watson J, et al. (2007) Early risk assessment for viral haemorrhagic fever: experience at the Hospital for Tropical Diseases, London, UK. The Journal of Infection 54: 6–11.
26. Atkin S, Anaraki S, Gothard P, Walsh A, Brown D, et al. (2009) The first case of Lassa fever imported from Mali to the United Kingdom, february 2009. Eurosurveillance 14: 1–3.
27. Kitching A, Addiman S, Cathcart S, Bishop L, Krahé D, et al. (2009) A fatal case of Lassa fever in London, January 2009. Eurosurveillance 14: 1–3.
28. Beeching NJ, Fletcher TE, Hill DR, Thomson GL, (2010) Travellers and viral haemorrhagic fevers: what are the risks? International Journal of Antimicrobial Agents 36 Suppl 1: S26–35.
29. Wallinga J, Teunis P, (2004) Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. American Journal of Epidemiology 160: 509–16.
30. Obadia T, Haneef R, Boëlle PY, (2012) The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks. BMC Medical Informatics and Decision Making 12: 147.
31. Allan R, Mardell S, Ladbury R, Pearce E, Skinner K (1999) The progression from endemic to epidemic Lassa fever in war-torn West Africa. In: Saluzzo J.F. and Dodet B. editors, Factors in the Emergence and Control of Rodent-borne Viral Diseases, Elsevier. pp.197–205.
32. McCormick J.B., Fisher-Hoch M (2002) Lassa Fever. In: Oldstone MBA, editor, Arenaviruses: The Epidemiology, Molecular and Cell Biology of Arenaviruses, Springer Berlin Heidelberg. pp.75–109.
33. Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, et al. (2000) Genetic diversity among Lassa virus strains. Journal Of Virology 74: 6992–7004.
34. Yalley-Ogunro JE, Frame JD, Hanson AP, (1984) Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia. Transactions of the Royal Society of Tropical Medicine and Hygiene 78: 764–70.
35. Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB, (1988) Viral hemorrhagic fever antibodies in Nigerian populations. The American Journal of Tropical Medicine and Hygiene 38: 407–10.
36. Boiro I, Lomonossov NN, Sotsinski VA, Constantinov OK, Tkachenko EA, et al. (1987) Clinico-epidemiologic and laboratory research on hemorrhagic fevers in Guinea. Bulletin de la Société de Pathologie Exotique et de ses Filiales 80: 607–12.
37. Lukashevich IS, Clegg JCS, Sidibe K, (1993) Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. Journal of Medical Virology 40: 210–217.
38. Ter Meulen J, Lukashevich I, Sidibe K, Inapogui A, Marx M, et al. (1996) Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. The American Journal of Tropical Medicine and Hygiene 55: 661–6.
39. Akoua-Koffi C, Ter Meulen J, Legros D, Akran V, Aïdara M, et al. (2006) Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast. Médecine Tropicale: Revue du Corps de Santé Colonial 66: 465–8.
40. Klempa B, Koulemou K, Auste B, Emmerich P, Thomé-Bolduan C, et al. (2013) Seroepidemiological study reveals regional co-occurrence of Lassa- and Hantavirus antibodies in Upper Guinea, West Africa. Tropical Medicine & International Health 18: 366–71.
41. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, et al. (1995) Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. British Medical Journal (Clinical Research Edition) 311: 857–9.
42. Tobin E, Asogun D, Isah E, Ugege O, Ebhodaghe P, (2013) Assessment of knowledge and attitude towards Lassa fever among primary care providers in an endemic suburban community of Edo state: implications for control. Journal of Medicine and Medical Sciences 4: 311–318.
43. Fisher-Hoch SP, (2005) Lessons from nosocomial viral haemorrhagic fever outbreaks. British Medical Bulletin 73-74: 123–37.
44. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/. ISBN 3-900051-07-0.
45. Stein RA, (2011) Super-spreaders in infectious diseases. International Journal of Infectious Diseases 15: e510–3.
46. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM, (2005) Superspreading and the effect of individual variation on disease emergence. Nature 438: 355–9.
47. Blumberg S, Lloyd-Smith JO, (2013) Inference of R0 and transmission heterogeneity from the size distribution of stuttering chains. PLoS Computational Biology 9: e1002993.
48. Kline SE, Hedemark LL, Davies SF, (1995) Outbreak of tuberculosis among regular patrons of a neighborhood bar. The New England Journal of Medicine 333: 222–7.
49. Paunio M, Peltola H, Valle M, Davidkin I, Virtanen M, et al. (1998) Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. American Journal of Epidemiology 148: 1103–1110.
50. Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, et al. (2003) Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (New York, NY) 300: 1961–6.
51. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, et al. (2003) Transmission dynamics and control of severe acute respiratory syndrome. Science (New York, NY) 300: 1966–70.
52. Shen Z, Ning F, Zhou W, He X, Lin C, et al. (2004) Superspreading SARS events, Beijing, 2003. Emerging Infectious Diseases 10: 256–60.
53. Leach M, Scoones I, (2013) The social and political lives of zoonotic disease models: narratives, science and policy. Social Science & Medicine 88: 10–17.
54. Leach M, (1994) Rainforest Relations: Gender and Resource Use Among the Mende of Gola, Sierra Leone. Edinburgh University Press 272 pp.
55. Gay NJ, Hesketh LM, Morgan-Capner P, Miller E, (1995) Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiology and Infection 115: 139–156.
56. Farrington CP, Kanaan MN, Gay NJ, (2003) Branching process models for surveillance of infectious diseases controlled by mass vaccination. Biostatistics (Oxford, England) 4: 279–95.